Keck faculty members lead and participate in many of the nation’s largest multi-center clinical trials and studies.

In the battle against devastating diseases such as cancer, stroke and heart disease, a major effort is the development and testing of new tactics: surgeries, drugs, radiation therapies, preventive therapies and combinations of those that might lead to a cure. Clinical trials contribute to finding new and better ways of treating diseases. For a complete list of resources visit the Clinical Trials Office (CTO) website.

USC Clinical Trials Office

USC CTO is the clinical research organization for the University of Southern California and performs various clinical research administration tasks—including contracting, Medicare coverage analysis, budgeting, fiscal management, purchasing, interim project staffing, and research billing compliance.

Moreover, the organization is focused on serving as an effective liaison between industry and the clinical research community, facilitating quick start-ups, developing and enabling strategic partnerships and strengthening relationships between the two by effective communication.

USC CTO delivers these services through highly trained staff and is dedicated to ensuring the work of the principal investigators is completed in a timely manner while adhering to all the regulations and laws governing human-subject clinical research.

For more information, call (323) 442-7218 or visit

Clinical Investigation Support Office

The Clinical Investigation Support Office (CISO) of the Norris Comprehensive Cancer Center supports clinical trials research for cancer center members. For further information, please contact the CISO at (323) 865-0451.

Other Resources

Southern California Clinical and Translational Science Institute (SC CTSI)

Created by the National Institutes of Health, the SC CTSI provides investigators with a range of research resources — from robust clinical trials units and $1.2 million per year in funding opportunities to mentorship and career development.

Institutional Review Board

The USC Health Sciences Institutional Review Board (IRB) is a panel of 36 scientists, researchers and others in the community who review and approve proposals for clinical trials conducted by investigators of USC. The board is responsible for reviewing each proposal for safety and ethical issues and ensures the protection of patients participating in research projects.

The IRB is managed by the USC Office of Research Advancement. For more information, call (323) 223-2340 or visit the IRB website.